Scientists say pandemic underlined need for speedy clinical trials, but most phase I units are in private sector. They urge trial sites in govt sector too, so focus is on public health, not profit.
IndiGo showed how a single point of failure can ripple across a sector. In defence, where there is no external fallback, the consequences are far more serious.
With the US-India trade deal yet to get done, rupee depreciation may be helping to mitigate India’s loss of competitiveness. The other problem is extreme despondence among overseas equity investors.
Of the total package, $649 million will be utilised for additional hardware, software, and support services, and the remaining for Major Defence Equipment (MDE).
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS